A new era of oral weight loss drugs has begun with the FDA approval of a GLP-1 pill, which may offer an alternative to injections like Wegovy and Zepbound. The long-term effectiveness of these weight loss treatments is being studied, with some research raising questions about their durability. The introduction of these oral medications is expanding the weight loss drug market, with some treatments becoming more accessible, including to certain Medicare beneficiaries at a lower cost.